[Skip to Content]
[Skip to Content Landing]
Special Article
June 26, 2000

Practical Guidelines for Clinicians Who Treat Patients With Amiodarone

Nora Goldschlager, MD; Andrew E. Epstein, MD; Gerald Naccarelli, MD; et al Brian Olshansky, MD; Braman Singh, MD; for the Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology
Author Affiliations
 

Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2000

Arch Intern Med. 2000;160(12):1741-1748. doi:10.1001/archinte.160.12.1741
Abstract

Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.

×